Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mereo Biopharma Group Plc

2.53
+0.04001.61%
Post-market: 2.530.00000.00%16:05 EST
Volume:2.05M
Turnover:5.07M
Market Cap:391.89M
PE:-8.05
High:2.55
Open:2.48
Low:2.37
Close:2.49
Loading ...

Mereo BioPharma initiated with a Buy at Jefferies

TIPRANKS
·
06 Dec 2024

Mereo Biopharma Group Plc: Strong Buy Rating Due to Promising Pipeline and Strategic Partnerships

TIPRANKS
·
06 Dec 2024

Red Metal amongst rare earth plays to benefit from neodymium magnet demand growth

Stockheads
·
06 Dec 2024

European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

MT Newswires Live
·
03 Dec 2024

Mereo BioPharma: Setrusumab Chugs Along With Possible Inflection Points

seekingalpha
·
27 Nov 2024

Mereo BioPharma files for common stock offering by holders

seekingalpha
·
26 Nov 2024

Mereo BioPharma files to sell 26.64M ordinary shares for holders

TIPRANKS
·
26 Nov 2024

Equinox sniffs shallow and high-grade titanium ahead of MRE for Brazilian play

The Market Herald
·
25 Nov 2024

High-grade scandium and REE intercepts point to carbonatite system for NYM

The Market Herald
·
20 Nov 2024

European Equities Traded in the US as American Depositary Decline Slightly in Tuesday Trading

MT Newswires Live
·
20 Nov 2024

European Equities Traded in the US as American Depositary Drop in Friday Trading, Down 2.8% for Week

MT Newswires Live
·
16 Nov 2024

Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conference

GlobeNewswire
·
14 Nov 2024

Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE), Mereo Biopharma Group Plc (MREO) and Fate Therapeutics (FATE)

TIPRANKS
·
14 Nov 2024

Mereo Biopharma Group Plc: Positive Developments and Strong Growth Potential Justify Buy Rating

TIPRANKS
·
14 Nov 2024

High-value magnet rare earth shows for Viridis in Brazil

The West Australian
·
14 Nov 2024

Mereo BioPharma Group Price Target Maintained With a $7.00/Share by Needham

Dow Jones
·
13 Nov 2024